The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tentori, L.
Right arrow Articles by Kruisbeek, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tentori, L.
Right arrow Articles by Kruisbeek, A. M.
Right arrowPubmed/NCBI databases
*Substance via MeSH

The Journal of Immunology, Vol 140, Issue 4 1089-1094, Copyright © 1988 by American Association of Immunologists


ARTICLES

Proliferation and production of IL-2 and B cell stimulatory factor 1/IL- 4 in early fetal thymocytes by activation through Thy-1 and CD3

L Tentori, DM Pardoll, JC Zuniga, J Hu-Li, WE Paul, JA Bluestone and AM Kruisbeek
Division of Cancer Treatment, National Cancer Institute, Bethesda, MD 20892.

To examine which cell surface molecules can operate as transducers of activation signals to early fetal thymocytes, we analyzed the ability of mAb to CD3 and Thy-1 to induce fetal thymocyte activation. Both proliferation and lymphokine secretion were used as measures of activation. We show that anti-CD3 antibodies induce activation of fetal thymocytes as early as day 13 of fetal thymus development, 2 days before CD3 can be detected by flow cytometry. In addition, an alternative activation signal can be delivered to fetal thymocytes through the Thy-1 molecule as early as it is expressed, i.e., day 13. Both CD3- and Thy-1-mediated activation of day 15 fetal thymocytes results in expansion of cells expressing a CD3-gamma delta receptor complex; no CD3-alpha beta receptor complex could be detected. IL-2 production induced by CD3- and Thy-1-induced activation of fetal thymocytes is evident at the 13th day of gestation. Finally, an additional lymphokine B cell stimulatory factor-1 (BSF-1)/IL-4 (so far known only to be produced by mature CD3- cells), is also produced by fetal thymocytes. The results demonstrate that at least two cell surface molecules, Thy-1 and CD3, can function as pathways of activation in fetal thymocytes, and that at least two lymphokines, IL-2 and BSF-1/IL-4, are produced upon activation. These findings may well reflect a role for the early appearance of CD3- cells in thymus ontogeny.


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Maeda, S. Fujimoto, and M. I. Greene
Suppressor T cells regulate the nonanergic cell population that remains after peripheral tolerance is induced to the Mls-1 antigen in T cell receptor Vbeta 8.1 transgenic mice
PNAS, November 2, 2000; (2000) 230449097.
[Abstract] [Full Text]


Home page
ScienceHome page
J. Strominger
Developmental biology of T cell receptors
Science, May 26, 1989; 244(4907): 943 - 950.
[Abstract] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Maeda, S. Fujimoto, and M. I. Greene
Suppressor T cells regulate the nonanergic cell population that remains after peripheral tolerance is induced to the Mls-1 antigen in T cell receptor Vbeta 8.1 transgenic mice
PNAS, November 21, 2000; 97(24): 13257 - 13262.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1988 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1988 by The American Association of Immunologists, Inc. All rights reserved.